Pediatric Psychopharmacology for Primary Care

Product Description
Completely updated and revised, the third edition provides primary care physicians with practice-tested, condition-specific treatment recommendations for various childhood mental disorders. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents.
It includes digital tools offering instant access to additional information on psychotropic medications.
TOPICS INCLUDE
Conceptual framework for prescribing psychotropics
Newly approved medications, changes in regulations and guidelines, and updates in the professional literature are included in this new edition
Medications for specific diagnoses—ADHD, anxiety, and depression
Food and Drug Administration approved antipsychotics and mood stabilizers and all other medications
What to do when treatment is unsuccessful
About the Author
Mark A. Riddle, MD, is a Professor of Psychiatry and Pediatrics at the Johns Hopkins University School of Medicine. His clinical work involves collaborating with primary care clinicians in a federally qualified health center and providing phone consultations to primary care clinicians. The focus of Dr Riddle’s research, teaching, and clinical practice is pediatric psychopharmacology, especially medication side effects. His publications include over 300 research articles, reviews, chapters, and edited volumes. He serves as a member of the NICHD-sponsored Data Monitoring Committee for the Best Pharmaceuticals for Children Act and as Chair of the Scientific Council of the NVLD Project. He was a member of the Institute of Medicine’s Committee on Review of Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act, and the principal investigator of an NIMH-sponsored, multisite study of interventions for children who have gained weight on antipsychotic medication, and the site-PI of a 6-year follow-up study of preschoolers who were treated with medication for ADHD. He was the Director of the Division of Child and Adolescent Psychiatry at Johns Hopkins from 1993-2009 and was the founding chair of the Interventions Review Committee for Disorders Involving Children and Their Families at the National Institute of Mental Health.
Rebecca Baum, MD, FAAP is a developmental behavioral pediatrician at The Olson Huff Center at Mission Children’s Hospital in Asheville, NC. She has led several clinical, educational, research, and quality improvement efforts at the state and national levels focused on improving care for children with behavioral health conditions. She is a consultant to the American Board of Pediatrics Foundation’s Behavioral/Mental Health Crisis efforts and chair of the American Board of Pediatrics’ subboard of Developmental Behavioral Pediatrics. She is a member of the American Academy of Pediatrics’ Committee on Psychosocial Aspects of Child and Family Health and liaison to the Section on Developmental Behavioral Pediatrics.
Jane Meschan Foy, MD, FAAP, has spent more than 35 years in pediatric primary care, public health, administration, and medical teaching. Her special interests include mental health services in pediatric primary care and school settings, access to health care for underserved populations, primary care of children with special health care needs, and residency training in mental health, community pediatrics, and advocacy.
Dr Foy received her bachelor of arts from Wellesley College and her doctorate of medicine from University of North Carolina at Chapel Hill School of Medicine. She completed her residency training in pediatrics at University of North Carolina hospitals. She has held several academic positions and is currently professor of pediatrics at Wake Forest University School of Medicine and medical director of the Northwest Community Care Network (a